Pancreatic Cancer Research

ResearcherChinese Academy of SciencesNo recent work listed

Bojing Chi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5072043769. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: 3 papers

Papers 4

  1. CircPTPRA promotes the progression of pancreatic ductal adenocarcinoma via the miR-140-5p/LMNB1 axis. Co-author DOI 10.1002/cam4.5869↗
  2. The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway. Co-author DOI 10.3389/fonc.2023.1138238↗
  3. Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway. Co-author DOI 10.3389/fonc.2023.1218781↗
  4. Increased expression of miR-194-5p through the circPVRL3/miR-194-5p/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by act… Co-author DOI 10.1186/s12935-022-02835-0↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fuming Xie · 4 shared papers, 2022–2023 · strength 0.62
  2. Wen Fu · 4 shared papers, 2022–2023 · strength 0.62
  3. Huaizhi Wang · 4 shared papers, 2022–2023 · strength 0.62
  4. Jingyang Yin · 3 shared papers, 2022–2023 · strength 0.45
  5. Shixiang Guo · 3 shared papers, 2022–2023 · strength 0.45
  6. Jianyou Gu · 2 shared papers, 2023 · strength 0.31
  7. Jianyou Gu · 1 shared paper, 2022 · strength 0.14
  8. Jianbo Li · 1 shared paper, 2022 · strength 0.14
  9. Lei Cai · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.